next generation peptidomimetic and tissue transglutaminase inhibitors (Zedira)

N/A

Report date: 2025/03/20 15:11:52
NME

Base Information

Drug Namenext generation peptidomimetic and tissue transglutaminase inhibitors (Zedira)
Drug Alias NameN/A
ClassificationSmall molecules > Peptidomimetic
Mechanisms of ActionProtein-glutamine gamma-glutamyltransferase inhibitors
TargetsProtein-glutamine gamma-glutamyltransferase
Therapy Area/IndicationsRenal fibrosisIdiopathic Pulmonary FibrosisLiver Cirrhosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesZedira GmbH
China Registration ClassN/A

Develop Information

Active CompaniesZedira GmbH
Inactive CompaniesN/A
Active IndicationsRenal fibrosisIdiopathic Pulmonary FibrosisLiver Cirrhosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A